000 01533 a2200469 4500
005 20250517113648.0
264 0 _c20171128
008 201711s 0 0 fre d
022 _a1769-6690
024 7 _a10.1016/j.medmal.2016.08.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHansmann, Y
245 0 0 _a[Lyme disease: The French Infectious Diseases Society's statement].
_h[electronic resource]
260 _bMedecine et maladies infectieuses
_cOct 2016
300 _a343-345 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aArachnid Vectors
_xmicrobiology
650 0 4 _aEvidence-Based Medicine
650 0 4 _aFrance
_xepidemiology
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aInfectious Disease Medicine
_xorganization & administration
650 0 4 _aLyme Disease
_xdiagnosis
650 0 4 _aSerologic Tests
650 0 4 _aSocieties, Medical
650 0 4 _aTick Bites
_xmicrobiology
650 0 4 _aTick-Borne Diseases
_xepidemiology
650 0 4 _aTicks
_xmicrobiology
700 1 _aChirouze, C
700 1 _aTattevin, P
700 1 _aAlfandari, S
700 1 _aCaumes, E
700 1 _aChristmann, D
700 1 _aSalomon, J
700 1 _aMichelet, C
700 1 _aRabaud, C
700 1 _aRoblot, F
773 0 _tMedecine et maladies infectieuses
_gvol. 46
_gno. 7
_gp. 343-345
856 4 0 _uhttps://doi.org/10.1016/j.medmal.2016.08.001
_zAvailable from publisher's website
999 _c26387607
_d26387607